Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Day One Biopharmaceuticals Inc (DAWN)

Day One Biopharmaceuticals Inc (DAWN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Day One to Report Third Quarter 2024 Financial Results Wednesday, October 30, 2024 GlobeNewswire - Wed Oct 16, 7:30AM CDT

DAWN : 14.35 (-0.83%)
Day One Biopharmaceuticals (DAWN) Stock Soars 11.3% on Strategic Milestones and Promising Outlook
Day One Biopharmaceuticals (DAWN) Stock Soars 11.3% on Strategic Milestones and Promising Outlook wealthyventurecapitalist.com - Wed Jun 26, 9:52AM CDT

Shares of Day One Biopharmaceuticals (NASDAQ: DAWN) surged 11.3% this morning, reflecting strong investor confidence fueled by a series of favorable developments. This biotech firm focused on advancing...

DAWN : 14.35 (-0.83%)
KAZIA THERAPEUTICS ANNOUNCES PHASE II CLINICAL STUDY TO INVESTIGATE PAXALISIB IN RECURRENT/PROGRESSIVE IDH-MUTANT GRADE 2 & 3 GLIOMA PR Newswire - Thu Jun 8, 2023

/PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce that it is supporting...

KZIA : 5.39 (+15.67%)
DAWN : 14.35 (-0.83%)
NVS : 110.53 (-4.41%)
Wall Street - shutterstock_1321462394
Stock Index Futures Muted as Weak China Trade Data Weighs on Sentiment Barchart - Wed Jun 7, 2023

June S&P 500 futures (ESM23) are up +0.14%, and June Nasdaq 100 E-Mini futures (NQM23) are up +0.09% this morning as weak trade data from China stoked investor concerns over the strength of global demand....

ESM23 : 4,453.35s (+0.61%)
NQM23 : 15,316.61s (+0.85%)
PACW : 7.54 (-2.71%)
WAL : 83.94 (-0.97%)
INTC : 22.90 (-0.09%)
AMD : 166.25 (+3.96%)
COIN : 219.66 (+1.65%)
ITX.E.DX : 53.900 (-1.06%)
YEXT : 7.21 (+2.12%)
GDYN : 16.20 (+1.00%)
VXRT : 0.7955 (-4.74%)
DAWN : 14.35 (-0.83%)
Why Shares of Day One Pharmaceuticals Are Up Monday Motley Fool - Mon Jun 5, 2023

The clinical-stage biotech released early trial news regarding its lead therapy candidate.

DAWN : 14.35 (-0.83%)
Wall Street - shutterstock_1321462400
Stock Index Futures Mixed on Pressure from Rising Bond Yields, Oil Prices Rise After Saudi Output Cuts Barchart - Mon Jun 5, 2023

June S&P 500 futures (ESM23) are up +0.01%, and June Nasdaq 100 E-Mini futures (NQM23) are down -0.25% this morning as market participants digested the U.S. debt ceiling agreement, while U.S. Treasury...

ESM23 : 4,453.35s (+0.61%)
NQM23 : 15,316.61s (+0.85%)
LULU : 304.82 (-0.88%)
MMM : 129.27 (-0.78%)
AMZN : 190.83 (+1.30%)
VOLCB.S.DX : 23.390 (-0.59%)
MRO : 25.88 (-0.88%)
DVN : 38.14 (-1.17%)
OXY : 50.08 (-1.09%)
DBRG : 16.39 (-1.03%)
RAIN : 1.2100 (-1.63%)
EVAX : 2.91 (+2.46%)
Neurofibromatosis Treatment Market Value Expected to Reach $27 Billion By End Of 2029 FinancialNewsMedia - Thu Jun 1, 2023

EQNX::TICKER_START (NASDAQ:KTTA),(NASDAQ:SWTX),(NASDAQ:DAWN),(NASDAQ:VSTM),(NASDAQ:KNTE) EQNX::TICKER_END

KTTA : 3.92 (+6.23%)
DAWN : 14.35 (-0.83%)
SWTX : 30.13 (+0.80%)
VSTM : 3.60 (+6.19%)
KNTE : 2.65 (-0.38%)
Neurofibromatosis Treatment Market Value Expected to Reach $27 Billion By End Of 2029 PR Newswire - Thu Jun 1, 2023

/PRNewswire/ -- Neurofibromatosis is a genetic condition that disrupts the cell growth in your nervous system, causing formation of tumors on nerve tissue....

KTTA : 3.92 (+6.23%)
SWTX : 30.13 (+0.80%)
DAWN : 14.35 (-0.83%)
VSTM : 3.60 (+6.19%)
KNTE : 2.65 (-0.38%)
Promising Developments Announced Ahead of 2023 ASCO Annual Meeting's Oral Presentations PR Newswire - Fri May 26, 2023

/PRNewswire/ -- USA News Group - The world's biggest cancer conference is set to roll again at American Society of Clinical Oncology (ASCO) 2023, with...

ONC.TO : 1.64 (-3.53%)
GILD : 88.08 (-0.77%)
IMGN : 31.23 (unch)
DAWN : 14.35 (-0.83%)
LEGN : 45.46 (+0.35%)
ONCY : 1.1900 (-2.46%)
Promising Developments Announced Ahead of 2023 ASCO Annual Meeting’s Oral Presentations FinancialNewsMedia - Fri May 26, 2023

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:GILD),(NASDAQ:IMGN),(NASDAQ:DAWN),(NASDAQ:LEGN) EQNX::TICKER_END

ONCY : 1.1900 (-2.46%)
ONC.TO : 1.64 (-3.53%)
GILD : 88.08 (-0.77%)
IMGN : 31.23 (unch)
DAWN : 14.35 (-0.83%)
LEGN : 45.46 (+0.35%)

Barchart Exclusives

2 Promising Growth Stocks to Buy and Hold for a Decade or Longer Barchart - 16 minutes ago
These two growth stocks could be great additions to a long-term buy-and-hold portfolio. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot